Stocks360

iShares Evolved U.S. Innovative Healthcare ETF (IEIH)

ETF analysis · CBOE · Financial Services · Asset Management

Share: Facebook X WhatsApp SMS
$34.13

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$36.79M
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
0.58
Day Range
$34.01 – $34.13
52-wk Range
$34.01 – $34.13
Avg Volume
N/A
Volume
7.02K

iShares Evolved U.S. Innovative Healthcare ETF (IEIH) is an exchange-traded fund in the Financial Services sector. Latest price: $34.13. Market cap $36.79M. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About iShares Evolved U.S. Innovative Healthcare ETF

The iShares Evolved U.S. Innovative Healthcare ETF (IEIH) primarily allocates its capital to the equity securities of U.S.-based pharmaceutical and biotechnology companies. Under typical market conditions, a minimum of 80% of the fund's net assets will be invested in the common stocks of firms across various market capitalizations, including large, mid, and small-cap companies. The ETF also targets enterprises categorized within the "Innovative Healthcare Evolved Sector" — specifically, those whose financial profiles have historically aligned with conventional pharmaceutical and biotechnology businesses. It is important to note that this fund operates as a non-diversified investment vehicle.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap